Catalyst Wire Dossier Catalyst Wire Dossier

Ansofaxine hydrochloride extended-release tablets

Ansofaxine hydrochloride · Luye Pharma Group Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ansofaxine hydrochloride extended-release tablets, covering 2021-11-15 to 2021-11-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Ansofaxine Hydrochloride Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD) [Phase 3]

See pricing